Concepedia
Statistics
Publications
9
Citations
393
H-Index
Active since
1986
Affiliations
Abbott Fund(Current)
Abbott (United States)
Immunosciences Lab (United States)
Thomas K. Shaughnessy is an author at Abbott Fund specializing in pharmacology, life sciences, and medicine.
Publications per year
1986–2017
3,5-Bis(trifluoromethyl)pyrazoles: A Novel Class of NFAT Transcription Factor Regulator
Stevan W. Djurić, Nwe Y. BaMaung, Anwer Basha et al. · Journal of Medicinal Chemistry · 2000 · 120 citations
Life Sciences, Immunology, Pharmacology +16
α4β2 neuronal nicotinic receptor positive allosteric modulation: An approach for improving the therapeutic index of α4β2 nAChR agonists in pain
Chih‐Hung Lee, Chang Zhu, John Malysz et al. · Biochemical Pharmacology · 2011 · 59 citations
Life Sciences, Neuroscience, Pharmacology +12
Dopamine D, but not D receptor agonists are emetogenic in ferrets
Mark A. Osinski, Marie E. Uchic, Terese Seifert et al. · Pharmacology Biochemistry and Behavior · 2005 · 51 citations
Medicine, Neuroscience, Pharmacology +13
The 5-Lipoxygenase Inhibitory Activity of Zileuton in In Vitro and In Vivo Models of Antigen-Induced Airway Anaphylaxis
Peter E. Malo, Randy L. Bell, Thomas K. Shaughnessy et al. · Pulmonary Pharmacology · 1994 · 39 citations
Life Sciences, Pharmacology, Hypersensitivity +7
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis
Matthew A. Hulverson, Ryan Choi, Samuel L.M. Arnold et al. · International Journal for Parasitology · 2017 · 39 citations · Full text
Pharmacy, Infectious Diseases, Medicinal Chemistry +14
1–5 of 9